Multiple Myeloma: Pharmacists as Therapy Experts | PTCE Pharmacy Connect

Educational Objectives

• Objective 1: Describe a strategy to mitigate potential adverse effects of MM therapies by altering the route of administration, dosing schedule, and use of supportive care medications

 

Kathryn Maples, PharmD, BCOP

Clinical Pharmacy Specialist, Multiple Myeloma

Winship Cancer Institute, Emory Healthcare

Atlanta, Georgia

 

Kathryn Maples, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: 
Consultant: GlaxoSmithKline, Janssen, Karyopharm, Sanofi

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity numbers 0290-0000-22-315-H01-P and 0290-0000-22-315-H01-T. The activity is available for CE credit through July 11, 2023.

 

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.